Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989948 · ClinicalTrials.gov registry record · NA

Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA

A NA study of Aortic Aneurysm, Thoracoabdominal, sponsored by Yale University.

Active
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT02989948 is a NA study of Aortic Aneurysm, Thoracoabdominal that is active but no longer recruiting, run by Yale University. The registered enrollment target is 38 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989948, a NA study of Aortic Aneurysm, Thoracoabdominal, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.

Interventions

  • DEVICE Physician-modified aortic endograft

Study Locations (1)

Connecticut

  • Yale New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2020-04-22
Est. Completion 2031-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02989948

The ClinicalTrials.gov registry entry for NCT02989948 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Aneurysm, Thoracoabdominal appearing as the primary indexed condition, and to 1 intervention - of which Physician-modified aortic endograft is the first listed.

NCT02989948 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02989948 about?

NCT02989948 is a clinical study titled "Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA". The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effe...

What is the current status of trial NCT02989948?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2020-04-22. Estimated completion is 2031-12-31.

What conditions does trial NCT02989948 study?

This clinical trial studies the following conditions: Aortic Aneurysm, Thoracoabdominal.

What interventions are being tested in trial NCT02989948?

The interventions under investigation include: Physician-modified aortic endograft (DEVICE).

Who is sponsoring clinical trial NCT02989948?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02989948 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Aneurysm, Thoracoabdominal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.